X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (44) 44
Newspaper Article (13) 13
Book / eBook (11) 11
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
jews (8) 8
israel (5) 5
female (4) 4
humans (4) 4
globalization (3) 3
history (3) 3
identity (3) 3
index medicus (3) 3
judaism (3) 3
male (3) 3
society (3) 3
antisemitism (2) 2
case studies (2) 2
ethnic identity (2) 2
football (2) 2
forecasts and trends (2) 2
history and criticism (2) 2
holocaust, jewish (2) 2
investments (2) 2
jews identity (2) 2
judaism, reform (2) 2
juifs (2) 2
liberal judaism (2) 2
management (2) 2
medicine, general & internal (2) 2
middle aged (2) 2
persecutions (2) 2
political science (2) 2
privatization (2) 2
reform judaism (2) 2
reform movement (2) 2
responsa (2) 2
soccer (2) 2
social change (2) 2
sociology (2) 2
sport (2) 2
studies (2) 2
war (2) 2
zionism (2) 2
1800-1948 (1) 1
1923-2016 (1) 1
1945 (1) 1
1995-2005 (1) 1
21e siecle (1) 1
21e si©·cle (1) 1
21e siècle (1) 1
89.70 international relations: general (1) 1
abl inhibitor (1) 1
acupuncture (1) 1
acute disease (1) 1
addresses, essays, lectures (1) 1
aged (1) 1
aged, 80 and over (1) 1
alternative medicine (1) 1
analysis (1) 1
animals (1) 1
anionische polymerisation (1) 1
anthologies (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antisemitism soviet union (1) 1
antisemitisme (1) 1
antisemitismus (1) 1
antisemitismus / sowjetunion (1) 1
antitumor immunity (1) 1
area studies (1) 1
armed forces (1) 1
armies (1) 1
associations (1) 1
athletes (1) 1
attitude of health personnel (1) 1
attorneys general (1) 1
aufsatzsammlung (1) 1
auschwitz (1) 1
auschwitz konzentrationslager (1) 1
aussenpolitik von staaten (1) 1
autobiografie (1) 1
autobiographie (1) 1
autobiographies (1) 1
balance of power (1) 1
beitar jerusalem (1) 1
besluitvorming (1) 1
betriebswirtschaftslehre (1) 1
bias (1) 1
biographies (1) 1
biography (1) 1
biomedicine (1) 1
block copolymers (1) 1
blockcopolymer (1) 1
bone mineral density (1) 1
bortezomib - administration & dosage (1) 1
bortezomib - adverse effects (1) 1
bosutinib (1) 1
breast-cancer (1) 1
bullying (1) 1
business (1) 1
business administration (1) 1
business enterprises (1) 1
business enterprises finance (1) 1
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
St. Michael's College (John M. Kelly) - 3rd Floor (2) 2
Trinity College (John W Graham) - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Knox College (Caven) - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1588 - 1588
Abstract Background: Chronic-phase chronic myeloid leukemia (CP-CML) patients treated with tyrosine kinase inhibitors (TKIs) can expect to achieve high... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4751 - 4751
INTRODUCTION: Chronic myeloid leukemia (CML) is a bone marrow and blood disorder accounting for 15% of adult leukemia. Tyrosine kinase inhibitors (TKIs) have... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3567 - 3567
Abstract INTRODUCTION: Chronic myeloid leukemia (CML) is a bone marrow and blood disorder accounting for 15% of adult leukemia. A shift in CML management has... 
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 09/2017, Volume 17, pp. S329 - S330
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 3154 - 3154
Abstract INTRODUCTION: Prior to the introduction of bosutinib and ponatinib, CP-CML patients who had failed 2 prior lines of TKI had limited treatment options... 
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 03/2019, Volume 35, Issue 3, pp. 479 - 487
Objective: Comparing the benefit-risk profiles of ponatinib vs. bosutinib in third-line (3L) treatment of chronic phase chronic myeloid leukemia (CP-CML) is... 
chronic myeloid leukemia | chronic myelogenous leukemia | ponatinib | tyrosine kinase inhibitor | Indirect comparison | bosutinib | MEDICINE, RESEARCH & EXPERIMENTAL | COMPARATIVE EFFICACY | DASATINIB | NILOTINIB | ABL INHIBITOR | MEDICINE, GENERAL & INTERNAL | IMPACT | THERAPY | IMATINIB | SKI-606 | MUTATIONS
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3027 - 3027
Abstract Introduction: Panobinostat (PAN) is a potent pan-deacetylase inhibitor that targets multiple myeloma (MM) cells via its effects on epigenetics and... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 30 - 30
Abstract Background Multiple studies have shown the clinical activity of alvocidib followed by cytarabine and mitoxantrone in newly diagnosed and... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1017 - 1017
Abstract Background: Patients ≥55 years of age with active, relapsed or refractory acute myeloid leukemia (R/R AML) who have failed standard induction... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1457 - 1457
Abstract Background: Older patients (pts) with AML unfit for intense induction chemotherapy have a poor prognosis with a 5 year survival of <10%.... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4253 - 4253
Abstract Introduction: Tyrosine kinase inhibitor (TKI) discontinuation is being investigated in pts with CML-CP with sustained DMR (defined here as MR4.5 or... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4050 - 4050
Abstract Background: 225Ac-lintuzumab is a radioimmunoconjugate composed of 225Ac (t½=10 days), which emits 4 α-particles, linked to a humanized anti-CD33... 
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 10/2019, pp. 1 - 10
Treatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase (CML-CP) is considered a feasible option, especially with the ability... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3794 - 3794
Abstract Background: The use of short-ranged (50-80 µm), high-energy (~100 keV/µm) α particle-emitting isotopes for radioimmunotherapy may result in more... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 104 - 104
Abstract Introduction DLBCL is the most common lymphoid neoplasm in adults (Swerdlow 2016). While durable CRs are achieved in approximately 70% of patients... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.